Skip to main content
Journal cover image

Harnessing the Power of Real-World Evidence (RWE): A Checklist to Ensure Regulatory-Grade Data Quality.

Publication ,  Journal Article
Miksad, RA; Abernethy, AP
Published in: Clinical pharmacology and therapeutics
February 2018

The role of real-world evidence (RWE) in regulatory, drug development, and healthcare decision-making is rapidly expanding. Recent advances have increased the complexity of cancer care and widened the gap between randomized clinical trial (RCT) results and the evidence needed for real-world clinical decisions. Instead of remaining invisible, data from the >95% of cancer patients treated outside of clinical trials can help fill this void.

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Clinical pharmacology and therapeutics

DOI

EISSN

1532-6535

ISSN

0009-9236

Publication Date

February 2018

Volume

103

Issue

2

Start / End Page

202 / 205

Related Subject Headings

  • Translational Research, Biomedical
  • Risk Assessment
  • Pharmacology & Pharmacy
  • Patient Safety
  • Models, Theoretical
  • Learning
  • Humans
  • Evidence-Based Medicine
  • Drug Discovery
  • Drug Development
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Miksad, R. A., & Abernethy, A. P. (2018). Harnessing the Power of Real-World Evidence (RWE): A Checklist to Ensure Regulatory-Grade Data Quality. Clinical Pharmacology and Therapeutics, 103(2), 202–205. https://doi.org/10.1002/cpt.946
Miksad, Rebecca A., and Amy P. Abernethy. “Harnessing the Power of Real-World Evidence (RWE): A Checklist to Ensure Regulatory-Grade Data Quality.Clinical Pharmacology and Therapeutics 103, no. 2 (February 2018): 202–5. https://doi.org/10.1002/cpt.946.
Miksad RA, Abernethy AP. Harnessing the Power of Real-World Evidence (RWE): A Checklist to Ensure Regulatory-Grade Data Quality. Clinical pharmacology and therapeutics. 2018 Feb;103(2):202–5.
Miksad, Rebecca A., and Amy P. Abernethy. “Harnessing the Power of Real-World Evidence (RWE): A Checklist to Ensure Regulatory-Grade Data Quality.Clinical Pharmacology and Therapeutics, vol. 103, no. 2, Feb. 2018, pp. 202–05. Epmc, doi:10.1002/cpt.946.
Miksad RA, Abernethy AP. Harnessing the Power of Real-World Evidence (RWE): A Checklist to Ensure Regulatory-Grade Data Quality. Clinical pharmacology and therapeutics. 2018 Feb;103(2):202–205.
Journal cover image

Published In

Clinical pharmacology and therapeutics

DOI

EISSN

1532-6535

ISSN

0009-9236

Publication Date

February 2018

Volume

103

Issue

2

Start / End Page

202 / 205

Related Subject Headings

  • Translational Research, Biomedical
  • Risk Assessment
  • Pharmacology & Pharmacy
  • Patient Safety
  • Models, Theoretical
  • Learning
  • Humans
  • Evidence-Based Medicine
  • Drug Discovery
  • Drug Development